Masafumi Toyoshima

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 14

Top Venues

BMJ case reports

Cancers

The journal of obstetrics and gynaecology research

Journal of gynecologic oncology

Tohoku University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Tohoku University

Japan

PHD :: OB-GY

Publications

Riho Kojima, Masafumi Toyoshima, Akihito Yamamoto, Shunji Suzuki
Preoperative screening endometrial cytology discovered incidental gynaecological malignancy in two patients undergoing risk-reducing salpingo-oophorectomy. BMJ case reports 16 (3) (2023)
Mio Naito, Mika Terasaki, Nozomi Ouchi, Masafumi Toyoshima
Uterine carcinosarcoma showing immature teratoid-like differentiation. BMJ case reports 16 (12) (2023)
Kazuho Nakanishi, Masafumi Toyoshima, Yuta Ueno, Shunji Suzuki
A Retrospective Study Comparing Olaparib and Bevacizumab as a Maintenance Therapy for Platinum-Sensitive Recurrent Ovarian Cancer: Impact on Recurrence-Free Survival in Japanese and Asian Populations. Cancers 15 (10) (2023)
Mio Naito, Mika Terasaki, Nozomi Ouchi, Masafumi Toyoshima
Uterine carcinosarcoma showing immature teratoid-like differentiation. BMJ case reports 16 (12) (2023)
Masafumi Toyoshima, Eiji Kobayashi, Yoshito Terai, Tsuyoshi Yamashita, Yasuhisa Terao, Hiroyuki Nomura, Hironori Asada, Tsutomu Hoshiba, Mikio Mikami, Masaki Mandai, Osamu Wada-Hiraike, Shigeo Akira, Yutaka Osuga, Takuma Fujii, null null
Questionnaire survey regarding current status of minimally invasive surgery for endometrial cancer in Japan: A cross-sectional survey for JSGOE members. The journal of obstetrics and gynaecology research (2023)
Riho Kojima, Masafumi Toyoshima, Akihito Yamamoto, Shunji Suzuki
Preoperative screening endometrial cytology discovered incidental gynaecological malignancy in two patients undergoing risk-reducing salpingo-oophorectomy. BMJ case reports 16 (3) (2023)
Mio Naito, Mika Terasaki, Nozomi Ouchi, Masafumi Toyoshima
Uterine carcinosarcoma showing immature teratoid-like differentiation. BMJ case reports 16 (12) (2023)
Mio Naito, Mika Terasaki, Nozomi Ouchi, Masafumi Toyoshima
Uterine carcinosarcoma showing immature teratoid-like differentiation. BMJ case reports 16 (12) (2023)
Mio Naito, Mika Terasaki, Nozomi Ouchi, Masafumi Toyoshima
Uterine carcinosarcoma showing immature teratoid-like differentiation. BMJ case reports 16 (12) (2023)
Mio Naito, Mika Terasaki, Nozomi Ouchi, Masafumi Toyoshima
Uterine carcinosarcoma showing immature teratoid-like differentiation. BMJ case reports 16 (12) (2023)
Riho Kojima, Masafumi Toyoshima, Akihito Yamamoto, Shunji Suzuki
Preoperative screening endometrial cytology discovered incidental gynaecological malignancy in two patients undergoing risk-reducing salpingo-oophorectomy. BMJ case reports 16 (3) (2023)
Yuta Ueno, Masafumi Toyoshima, Daisuke Shigemi, Asuna Yumori, Reina Wakabayashi, Masakazu Kitagawa, Katsuyuki Konnai, Ryo Onose, Shunji Suzuki, Hisamori Kato
Significance of positive peritoneal cytology for recurrence and survival in patients with endometrial cancer. The journal of obstetrics and gynaecology research (2022)
Xuewei Zhang, Masumi Ishibashi, Kazuyuki Kitatani, Shogo Shigeta, Hideki Tokunaga, Masafumi Toyoshima, Muneaki Shimada, Nobuo Yaegashi
Potential of Tyrosine Kinase Receptor TIE-1 as Novel Therapeutic Target in High-PI3K-Expressing Ovarian Cancer. Cancers 12 (6) (2020)
Yusuke Shibuya, Masafumi Toyoshima, Nobuo Yaegashi
ASGO 4th International Workshop on Gynecologic Oncology. Journal of gynecologic oncology 28 (1) (2017)

Masafumi Toyoshima.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Masafumi Toyoshima